Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury
Cardiovascular disease (CVD) continues to be the leading cause of death in the world. Increased inflammation and an enhanced thrombotic milieu represent two major complications of CVD, which can culminate into an ischemic event. Treatment for these life-threatening complications remains reperfusion...
Main Authors: | Junaid Ansari, Gaganpreet Kaur, Felicity N. E. Gavins |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/4/1211 |
Similar Items
-
Annexin A1 protects against cerebral ischemia–reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway
by: Xin Xu, et al.
Published: (2021-05-01) -
Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac2-26, Against Myocardial Infarction
by: Cheng Xue Qin, et al.
Published: (2019-04-01) -
Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation
by: Shantel A. Vital, et al.
Published: (2020-11-01) -
2-Methoxyestradiol Protects Against Lung Ischemia/Reperfusion Injury by Upregulating Annexin A1 Protein Expression
by: Wen-I Liao, et al.
Published: (2021-03-01) -
New Insights on Formyl Peptide Receptor Type 2 Involvement in Nociceptive Processes in the Spinal Cord
by: Mariantonella Colucci, et al.
Published: (2022-03-01)